NCT06073548View on ClinicalTrials.gov

Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method Study

Not yet recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

April 1, 2026

Conditions
Uveal Melanoma
Interventions
OTHER

Questionnaires and interviews

Patients wiill be asked to fulfill questionnaires at inclusion and 6 months after. An interview will be offered to a sub-sample of patients (approximately 20 patients).

All Listed Sponsors
lead

Institut Curie

OTHER

NCT06073548 - Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method Study | Biotech Hunter | Biotech Hunter